Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Stress can alter immunological, neurochemical and endocrinological functions, but its role in cancer progression is not well understood. Here, we show that chronic behavioral stress results in higher levels of tissue catecholamines, greater tumor burden and more invasive growth of ovarian carcinoma cells in an orthotopic mouse model. These effects are mediated primarily through activation of the tumor cell cyclic AMP (cAMP)-protein kinase A (PKA) signaling pathway by the beta(2) adrenergic receptor (encoded by ADRB2). Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP2 and MMP9, and we found that angiogenic processes mediated the effects of stress on tumor growth in vivo. These data identify beta-adrenergic activation of the cAMP-PKA signaling pathway as a major mechanism by which behavioral stress can enhance tumor angiogenesis in vivo and thereby promote malignant cell growth. These data also suggest that blocking ADRB-mediated angiogenesis could have therapeutic implications for the management of ovarian cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [16]
In the citing paper
“The tumor-promoting effect of catecholamines is mainly mediated by the β2 adrenergic receptor (encoded by ADRB2) activating the cAMP-protein kinase A (PKA) signaling pathway, which is the main mechanism to enhance tumor angiogenesis in the body and promote the growth of malignant cells [(34, 35); Figure 2].”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [34]
In the citing paper
“Parallel effects have been observed in experimental animal models of cancer, and those analyses again identify a prominent role for SNS activation of β-adrenergic signaling [43], [44].”
From Human Social Genomics (2014) · cites this paper as [43]
Citations
Cites
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“Pharmacologic and genetic manipulations identify β-adrenergic signaling as a central mediator of stress effects in the model of stress used here, but these findings do not rule out the possibility that other neuroendocrine signaling pathways might modulate tumor cell biology under other circumstances (for example, str…”
BackgroundStress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationPassaniti, A., Taylor, R. M., Пили, Р., Guo, Y., Long, P., Haney, J. A., Pauly, R. R., Grant, D. S., & Martin, G. R. (1992) · PubMed · Cited by 806
Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery
Landen, C. N., Chavez-Reyes, A., Bucana, C., Schmandt, R., Deavers, M. T., Lopez-Berestein, G., & Sood, A. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0530 · Cited by 675 · cited 1×
“To facilitate in vivo distribution, we incorporated the siRNA into a neutral liposome, DOP”
MethodSelf-citationBasu, S., Nagy, J. A., Pal, S., Vasile, E., Eckelhoefer, I. A., Susan Bliss, V., Manseau, E. J., Dasgupta, P. S., Dvorak, H. F., & Mukhopadhyay, D. (2001) · Nature Medicine · doi:10.1038/87895 · Cited by 396
Social support, psychological distress, and natural killer cell activity in ovarian cancer
Lutgendorf, S. K., Sood, A. K., Anderson, B., McGinn, S., Maiseri, H., Dao, M., Sorosky, J. I., De Geest, K., Ritchie, J., & Lubaroff, D. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.015 · Cited by 345 · cited 1×
“Previous research emphasized the role of the immune system in mediating stress effects on tumor growth and metastasi”
BackgroundSelf-citationLutgendorf, S. K., Cole, S. W., Costanzo, E. S., Bradley, S., Coffin, J. E., Jabbari, S., Rainwater, K. K., Ritchie, J. M., Yang, M., & Sood, A. K. (2003) · PubMed · Cited by 330
Self-citation
Research works printed but not linked: 1
- Halder, J. et al. Focal adhesion kinase targeting for therapy of ovarian carcinoma using in vivo siRNA delivery in neutral liposomes. Clin. Cancer Res. (in the press).
Cited by
Items 501–600 of 1,000
Flint, M. S., Kim, G., Hood, B. L., Bateman, N. W., Stewart, N. A., & Conrads, T. P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.008 · Cited by 36
Valente, V. B., Verza, F. A., Lopes, F. Y. K., Ferreira, J. Z., dos Santos, P. S. P., Sundefeld, M. L. M. M., Biasoli, É. R., Miyahara, G. I., Soubhia, A. M. P., de Andrade, M., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.11.001 · Cited by 38
Social Defeat Stress, Sex, and Addiction-Like Behaviors
Shimamoto, A. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.009 · Cited by 38
Singh, N. K., Quyền, Đ. V., Kundumani‐Sridharan, V., Brooks, P. C., & Rao, G. N. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.106187 · Cited by 38
Sarkar, D. K., & Zhang, C. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-416673-8.00011-3 · Cited by 39
Budiu, R. A., Vlad, A., Nazario, L. A., Bathula, C. S., Cooper, K. L., Edmed, J., Thaker, P. H., Urban, J. A., Kaliński, P., Lee, A. V., et al. (2016) · Cancer and Clinical Oncology · doi:10.5539/cco.v6n1p12 · Cited by 37
“…(such as norepinephrine; NE) that positively influence carcinogenesis through mechanisms that increase proliferation, angiogenesis, and metastasis and that protect tumor cells from anoikis (Lee et al., 2009; Lutgendorf, Lamkin, Jennings, et al., 2008; Nilsson et al., 2007; Thaker et al., 2006).”
BackgroundInfluentialSelf-citationEnriched environment and stress exposure influence splenic B lymphocyte composition
Gurfein, B. T., Hasdemir, B., Milush, J. M., Touma, C., Palme, R., Nixon, D. F., Darcel, N., Hecht, F. M., & Bhargava, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180771 · Cited by 41
Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling
Liu, H., Yang, J., Zhang, Y., Han, J., Yang, Y., Zhao, Z., Dai, X., Wang, H., Ding, X., Liu, Y., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1043 · Cited by 35
“norepinephrine) and promotes the growth of tumors (21, 22).”
BackgroundPrognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma
Bravo-Calderón, D. M., Oliveira, D. T., Marana, A. N., Nonogaki, S., Carvalho, A. L., & Kowalski, L. P. (2012) · Cancer Biomarkers · doi:10.3233/cbm-2012-0228 · Cited by 34
“fluences cancer development and progression [1,4,11, 15,17,18].”
Avraham, R., Benish, M., Inbar, S., Bartal, I. B.-A., Rosenne, E., & Ben‐Eliyahu, S. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.03.010 · Cited by 34
“For example, Sood et al. reported that an adrenergic blocker reduced vascular endothelial growth factor (VEGF) secretion by malignant human cells, as well as their tissue invasiveness and growth (Sood et al. 2006; Thaker et al. 2006; Lee et al. 2009).”
Boulay, G., Malaquin, N., Loison, I., Foveau, B., Rechem, C. V., Rood, B. R., Pourtier, A., & Leprince, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304287 · Cited by 34
“Previous studies have shown that stress results in higher levels of tissue catecholamine followed by increased levels of proangiogenic factors such as IL-8 (interleukine-8), VEGF (vascular endothelial growth factor), and MMP (matrix metalloproteinase) resulting in enhanced tumor vascularization (16, 21) and invasion (…”
BackgroundMethodResultStress and long-term survivors of brain cancer
Keir, S. T., Swartz, J. J., & Friedman, H. S. (2007) · Supportive Care in Cancer · doi:10.1007/s00520-007-0292-1 · Cited by 34
Jansen, L., Weberpals, J. G., Kuiper, J. G., Vissers, P. A. J., Wolkewitz, M., Hoffmeister, M., & Brenner, H. (2017) · International Journal of Cancer · doi:10.1002/ijc.30717 · Cited by 34
“Experimental studies suggested that it is very likely that the sympathetic nerve system contributes to some of the eight hallmarks of cancer development.(7) These findings led to the idea of applying drugs which are acting in the adrenergic system, particularly beta-blockers, for the purpose of treating cancer.”
BackgroundHara, M., Takeba, Y., Iiri, T., Ohta, Y., Ootaki, M., Watanabe, M., Watanabe, D., Koizumi, S., Otsubo, T., & Matsumoto, N. (2018) · Cancer Science · doi:10.1111/cas.13861 · Cited by 34
Beta blockade as adjunctive breast cancer therapy: A review
Phadke, S. D., & Clamon, G. H. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.04.006 · Cited by 38
Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders
Kalinichenko, L. S., Kornhuber, J., & Müller, C. P. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100783 · Cited by 37
Rakshasa-Loots, A. M., & Tong, M. T. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00081 · Cited by 40
“, 2006), and increased tumor growth (Thaker et al., 2006).”
Jiang, S., Zhang, X.-X., Hu, L.-P., Wang, X., Li, Q., Zhang, X., Li, J., Gu, J., & Zhang, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.586757 · Cited by 36
Amaro, F., Silva, D., Reguengo, H., Oliveira, J. C., Quintas, C., Vale, N., Gonçalves, J., & Fresco, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217968 · Cited by 35
“The type involved in this modulation may differ according to the tissue: α1-adrenoceptors increase proliferation of gastric [19] and prostate [20] cancer cells; α2-adrenoceptors increase proliferation of breast cancer cells [21,22], whereas β-adrenoceptors, mainly β2, seem to increase cell proliferation of lung [23,24…”
BackgroundThe Use of Healing Touch in Integrative Oncology
Hart, L. K., Freel, M. I., Haylock, P. J., & Lutgendorf, S. K. (2011) · Clinical journal of oncology nursing · doi:10.1188/11.cjon.519-525 · Cited by 34
“Neuroendocrine stress hormones have been shown to enhance tumor growth, angiogenesis, and invasion, and to impair the cellular immune response (Antoni et al., 2006; Sood et al., 2006; Thaker et al., 2006).”
Self-citationAberrant nocturnal cortisol and disease progression in women with breast cancer
Zeitzer, J. M., Nouriani, B., Rissling, M. B., Sledge, G. W., Kaplan, K. A., Aasly, L., Palesh, O. G., Jo, B., Neri, E., Dhabhar, F. S., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3864-2 · Cited by 39
“While cortisol-mediated disruption of sleep may lead to shortened DFI [15], there are many other possible connections between the early night cortisol peak and shortened DFI, including mediation through sympathetic activation [35] or direct action of cortisol [36–38].”
BackgroundPellegata, N. S., Berriel Diaz, M., Rohm, M., & Herzig, S. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10058-y · Cited by 33
Yaman, İ., Çobanoğlu, D. A., Xie, T., Ye, Y., & Amit, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108199 · Cited by 38
Kelly, C. A., Trumpff, C., Acosta, C., Assuras, S., Baker, J., Basarrate, S., Behnke, A., Bo, K., Bobba‐Alves, N., Champagne, F. A., et al. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.08.006 · Cited by 39
“…childhood development and growth [13], cardiovascular diseases [14,15], diabetes [16], some aspects of cancer biology [17], psychiatric disorders [18,19], neurodegeneration and dementia [20], wound healing and resistance to viral infections [21,22], biological aging [23,24], and lifespan [25 – 28].”
Neurobiology of cancer: Adrenergic signaling and drug repurposing
Dong, Z.-K., Wang, Y., Li, W., & Jin, W. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108750 · Cited by 36
β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up
GIORGI, V. D., Grazzini, M., Benemei, S., Marchionni, N., Geppetti, P., & Gandini, S. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000317 · Cited by 33
Rodríguez-Rabassa, M., Hernández-Torres, R., Rodríguez, Z., Colón-Echevarria, C. B., Maldonado, L., Tollinchi-Natali, N., Torres-Marrero, E., Mulero, A., Albors, D., Pérez‐Morales, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66628-z · Cited by 33
Hopson, M. B., Lee, S., Accordino, M. K., Trivedi, M. S., Maurer, M., Crew, K. D., Hershman, D. L., & Kalinsky, K. M. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06210-x · Cited by 34
“Propranolol, a non-selective beta-adrenergic blocker with non-oncologic treatment indications including cardiovascular disease, has also been shown to regulate angiogenesis in primary breast tumors and reduce distant breast cancer metastases in observational studies [6,7,8,9,10,11].”
BackgroundPsychological intervention to treat distress: An emerging frontier in cancer prevention and therapy
Yang, M., Zhang, Z., Nice, E. C., Wang, C., Zhang, W., & Huang, C. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188665 · Cited by 39
Jacobsen, K. R., Kalliokoski, O., Teilmann, A. C., Hau, J., & Abelson, K. (2012) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2012.09.012 · Cited by 38
“Pain and stress may be significant confounders in various research settings and animal models [14,61,74,83].”
BackgroundGordon, J. S. (2008) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2008.04.010 · Cited by 42
Gurfein, B. T., Davidenko, O., Premenko‐Lanier, M., Milush, J. M., Acree, M. C., Dallman, M. F., Touma, C., Palme, R., York, V. A., Fromentin, G., et al. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00158 · Cited by 35
Gandhi, S., Pandey, M. R., Ammannagari, N., Wang, C., Bucsek, M. J., Hamad, L., Repasky, E. A., & Ernstoff, M. S. (2020) · Immunotherapy · doi:10.2217/imt-2019-0064 · Cited by 33
The Central Nervous Mechanism of Stress-Promoting Cancer Progression
Hong, Y., Zhang, L., Liu, N., Xu, X., Liu, D., & Tu, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012653 · Cited by 36
“The focus of recent research into the regulation of stress-related cancer progression has been NE and NE signaling since Thaker and colleagues found that NE and β-adrenergic receptor (β-AR) signaling induced by elevated chronic stress promotes tumor growth and angiogenesis in mice [54].”
BackgroundNeuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk
Fan, H., Liang, X., & Tang, Y. (2024) · MedComm · doi:10.1002/mco2.784 · Cited by 40
Xing, Y., & Liu, C. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02683-7 · Cited by 37
“Studies on prostate cancer [51] and ovarian cancer [52] con fi rm this phenomenon.”
Norepinephrine Stimulates Mobilization of Endothelial Progenitor Cells after Limb Ischemia
Jiang, Q., Ding, S., Wu, J., Liu, X., & Wu, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101774 · Cited by 32
“Several studies have indicated that chronic stress would increase tumor growth and metastasis by promoting tumor angiogenesis[30,31].”
BackgroundStress and cancer. Part II: Therapeutic implications for oncology
Mravec, B., Tibenský, M., & Horváthová, Ľ. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577312 · Cited by 35
Beta adrenergic receptor activation inhibits oral cancer migration and invasiveness
Bravo-Calderón, D. M., Assáo, A., Garcia, N. G., Coutinho‐Camillo, C. M., Roffé, M., Germano, J. N., & Oliveira, D. T. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104865 · Cited by 32
Social isolation stress facilitates chemically induced oral carcinogenesis
Verza, F. A., Valente, V. B., Oliveira, L. K., Kayahara, G. M., Crivelini, M. M., Furuse, C., Biasoli, É. R., Miyahara, G. I., Oliveira, S. H. P., & Bernabé, D. G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245190 · Cited by 35
“Chronic stress may promote cancer progression through an enhanced tissue expression of tumor progression-related molecules [57].”
BackgroundRethinking Yoga and the Application of Yoga in Modern Medicine
Chaoul, M. A., & Cohen, L. (2010) · CrossCurrents · doi:10.1111/j.1939-3881.2010.00117.x · Cited by 42
Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
Lu, D., Sinnott, J. A., Valdimarsdóttir, U. A., Fang, F., Gerke, T. A., Tyekucheva, S., Fiorentino, M., Lambe, M. P., Sesso, H. D., Sweeney, C. J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0101 · Cited by 32
“Thaker and colleagues found that activation of the adrenergic signaling pathway promoted tumor proliferation and angiogenesis in an ovarian cancer model (33).”
Hylander, B. L., Eng, J. W. ‐., & Repasky, E. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_12 · Cited by 35
“It has previously been reported that the catecholamine levels are higher in the tissues of tumor-bearing mice subjected to restraint stress in experiments conducted at ST [101].”
BackgroundEffect of chronic stress on tumorigenesis and development
Wang, C., Shen, Y., Ni, J., Hu, W., & Yang, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04455-3 · Cited by 36
“In mouse models of ovarian cancer [90], oral cancer [91] and prostate cancer [92], chronic stress increases the metastasis of the tumors.”
BackgroundJeong, J.-H., Park, H.-J., Park, S., Choi, Y. H., & Chi, G. (2022) · Molecules · doi:10.3390/molecules27185940 · Cited by 31
“In mouse models, chronic restraint stress stimulated angiogenesis and promoted tumor growth in pancreatic cancer and ovarian cancer by activating β2-AR [12,13].”
BackgroundSeiler, A., Milliken, A. B., Leiter, R. E., Blum, D., & Slavich, G. M. (2024) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2024.100226 · Cited by 38
“These effects may have long-lasting consequences, including DNA mutations, and thereby increase the potential for abnormal cellular transformation [111 – 113].”
BackgroundCircadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology
Gnocchi, D., Custodero, C., Sabbà, C., & Mazzocca, A. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01780-2 · Cited by 39
Norepinephrine promotes glioma cell migration through up-regulating the expression of Twist1
Wang, X., Wang, Y., Xie, F., Song, Z.-T., Zhang, Z., Zhao, Y. F., Wang, S.-D., Hu, H., Zhang, Y., & Qian, L. (2022) · BMC Cancer · doi:10.1186/s12885-022-09330-9 · Cited by 36
Atherton, M. A., Park, S., Horan, N. L., Nicholson, S. J., Dolan, J. C., Schmidt, B. L., & Scheff, N. N. (2022) · Pain · doi:10.1097/j.pain.0000000000002655 · Cited by 32
Belotti, Y., Tolomeo, S., Yu, R., Lim, W., & Lim, C. T. (2022) · Cancers · doi:10.3390/cancers14102544 · Cited by 35
“Specifically, adrenergic receptor activation elicits the secretion of the vascular endothelial growth factor (VEGF), angiogenesis, and enhances tumor progression [16,17].”
BackgroundHuang, T., Tworoger, S. S., Hecht, J. L., Rice, M. S., Sood, A. K., Kubzansky, L. D., & Poole, E. M. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0534 · Cited by 33
“In mice, chronic restraint stress led to larger and more aggressive ovarian tumors; blockade of b2-adrenergic signaling by inhibiting tumor ADRB2s abrogated the effect of chronic stress on tumor progression (6).”
BackgroundSelf-citationSalter, R. D., & Shurin, M. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4 · Cited by 33
Yu, J., Liu, T., Gao, Z., Liu, R., Wang, Z., Chen, Y., Cao, J., & Dong, Y. (2022) · Nutrients · doi:10.3390/nu14153164 · Cited by 31
“The restraint stress procedure follows the approach previously reported [24,25].”
MethodWang, Y., Dong, Z.-K., & Jin, W. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02396-6 · Cited by 34
“A growing body of preclinical and clinical research now shows that modulating the nervous system impacts the growth and spread of solid tumors in vivo as well as their response to therapy [27, 168–170].”
Sood, A. K., & Lutgendorf, S. K. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0358 · Cited by 32
“invasion, migration, and proliferation (12, 20).”
Self-citationSocial Regulation of Gene Expression in the Immune System
Cole, S. W. (2012) · The Oxford Handbook of Psychoneuroimmunology · doi:10.1093/oxfordhb/9780195394399.013.0014 · Cited by 30
Self-citationGjyshi, A., Dash, S., Cen, L., Cheng, C., Zhang, C. H., Yoder, S., Teer, J. K., Armaiz-Peña, G. N., & Monteiro, Á. N. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-26670-4 · Cited by 30
Chang, P., Chung, C., Chang, W., Lin, C., Lin, H., Dai, M., Ho, C., & Chien, W. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216828 · Cited by 30
Zinnah, K. M. A., Seol, J., & Park, S. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4635 · Cited by 31
“A number of studies in animal models have shown that behavioral stress induces the rapid progression of ovarian cancer (32), pancreatic cancer (33), prostate cancer (34), breast carcinomas (35) and malignant melanomas (36).”
BackgroundVascular endothelial growth factor and psychosocial factors in colorectal cancer
Sharma, A., Greenman, J., Sharp, D. M., Walker, L. G., & Monson, J. R. T. (2007) · Psycho-Oncology · doi:10.1002/pon.1191 · Cited by 32
Wu, X., Liu, B., Ji, S.-M., WU, J.-F., Xu, C., Du, Y., You, X., Li, B., Le, J., XU, H.-L., et al. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3559 · Cited by 34
β-blockers: a novel class of antitumor agents
Ji, Y., Chen, Xiao, X., Shan, & Kai (2012) · OncoTargets and Therapy · doi:10.2147/ott.s38403 · Cited by 36
“effects were mediated primarily through the activation of the tumor cell cAMP/PKA signaling pathway by β 2 -AR.(27,99,101,102)”
BackgroundExpanding Our Therapeutic Options: Beta Blockers for Breast Cancer?
Ganz, P. A., & Cole, S. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.8820 · Cited by 30
Self-citationLiang, Y., Du, M., Li, X., Gao, J., Li, Q., Li, H., Li, J., Gao, X., Cong, H., Huang, Y., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2470372 · Cited by 34
“Animal studies have demonstrated that exposure to distress environments such as social defeat, 9 social isolation 10 and chronic restraint stress 11 substantially facilitate cancer growth and compromise anti-tumor immunity.”
Shi, Y., Luo, J., Wang, X., Zhang, Y., Zhu, H., Su, D., Yu, W., & Tian, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.800499 · Cited by 30
Ren, Q., Luo, F., Ge, S., & Chen, P. (2022) · Cancer Medicine · doi:10.1002/cam4.5043 · Cited by 30
A Her2-let-7-β2-AR circuit affects prognosis in patients with Her2-positive breast cancer
Liu, D., Deng, Q., Sun, L., Wang, T., Yang, Z., Chen, H., Guo, L., Liu, Y., Yuan-fang Ma, A., Guo, N., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1869-6 · Cited by 31
“Several studies including ours showed that β2-AR is overly expressed in a variety of tumor tissues, including ovarian, breast, prostate, and gastric cancers and catecholamines manipulate the biobehaviors of tumor cells mainly through activation of the β2-AR-mediated signaling pathways [3, 4, 8–11].”
BackgroundHeitz, F., Hengsbach, A., Harter, P., Traut, A., Ataseven, B., Schneider, S. E., Prader, S., Kurzeder, C., Sporkmann, M., & du Bois, A. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.11.012 · Cited by 29
Prognostic significance of β2-adrenergic receptor expression in non-small cell lung cancer.
Yazawa, T., Kaira, K., Shimizu, K., Shimizu, A., Mori, K. P., Nagashima, T., Ohtaki, Y., Oyama, T., Mogi, A., & Kuwano, H. (2016) · PubMed · Cited by 29
Stress alters the expression of cancer-related genes in the prostate
Flores, I., Sierra-Fonseca, J. A., Davalos, O., Saenz, L. A., Castellanos, M. M., Zavala, J., & Gosselink, K. L. (2017) · BMC Cancer · doi:10.1186/s12885-017-3635-4 · Cited by 33
“Suppression of T cell function by chronic stress is also known to increase susceptibility to skin cancer [11], and β-adrenergic signaling has been shown to be linked to tumor growth and invasion in pancreatic and ovarian cancers [12, 13].”
BackgroundLi, W., & Zhao, Y. (2018) · Asian Journal of Andrology · doi:10.4103/aja.aja_32_18 · Cited by 32
Social Integration, Marital Status, and Ovarian Cancer Risk: A 20-Year Prospective Cohort Study
Trudel‐Fitzgerald, C., Poole, E. M., Sood, A. K., Okereke, O. I., Kawachi, I. I., Kubzansky, L. D., & Tworoger, S. S. (2019) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000747 · Cited by 32
Self-citationCui, B., He, B., Huang, Y., Wang, C., Luo, H., Lü, J., Su, K., Zhang, X., Luo, Y., Zhao, Z., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06200-5 · Cited by 35
“Compared with control mice, cGMP levels in tumors from stressed-mice were elevated, which could be reversed by ablation of PYCR1 (Fig.”
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
Reavis, H. D., Gysler, S. M., McKenney, G. B., Knarr, M., Lusk, H. J., Rawat, P., Rendulich, H. S., Mitchell, M. A., Berger, D. S., Moon, J. S., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.170961 · Cited by 35
“In the scope of HGSC, independent studies indicate that the pro-tumorigenic effects of NE are mediated by β -ARs (51, 53–55, 57–59, 63), as opposed to α -adrenergic receptors (52, 56).”
BackgroundSiwik, C. J., Hicks, A., Phillips, K. M., Rebholz, W. N., Zimmaro, L. A., Weissbecker, I., Cash, E. D., & Sephton, S. E. (2017) · Journal of Health Psychology · doi:10.1177/1359105317740737 · Cited by 32
“In the cancer context, perceived stress can affect biological and clinical outcomes, such as tumor progression, angiogenesis (Thaker et al., 2006), and survival (Chida et al., 2008).”
BackgroundClément-Demange, L., Mulcrone, P. L., Tabarestani, T. Q., Sterling, J. A. R., & Elefteriou, F. (2018) · Journal of bone oncology · doi:10.1016/j.jbo.2018.09.002 · Cited by 28
“Activation of the hypothalamic-pituitary axis (HPA) and of the sympathetic nervous system (SNS) are hallmarks of prolonged stress, and recent studies have shown that chronic stress exacerbates cancer progression in animal models of prostate [13], ovarian [14,15] and breast cancers [16–18], as well as in some cancer pa…”
BackgroundLu, Y., Zhao, H., Liu, Y., Zuo, Y., Xu, Q., Liu, L., Li, X., Zhu, H., Zhang, Y., Zhang, S., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.709057 · Cited by 34
“By adopting the animal models of ovarian cancer, Thaker and colleagues identified the vital part of b2-AR in stress-mediated tumour progression through enhancing angiogenesis (4).”
BackgroundMethodInfluentialSelf-citationBlood Vessels and Peripheral Nerves as Key Players in Cancer Progression and Therapy Resistance
Roda, N., Blandano, G., & Pelicci, P. G. (2021) · Cancers · doi:10.3390/cancers13174471 · Cited by 32
Hylander, B. L., Repasky, E. A., & Sexton, S. (2022) · Animals · doi:10.3390/ani12030371 · Cited by 30
“The first is restraint stress in which a mouse is placed in a 50 mL conical tube for several hours at a time for several days in a row [80,108].”
BackgroundZhang, S., Yu, F., Che, A., Tan, B., Huang, C., Chen, Y., Liu, X., Huang, Q., Zhang, W., Ma, C., et al. (2022) · Advanced Science · doi:10.1002/advs.202104132 · Cited by 37
Circulating prolactin levels and risk of epithelial ovarian cancer
Clendenen, T. V., Arslan, A. A., Lokshin, A. E., Liu, M., Lundin, E., Koenig, K. L., Berrino, F., Hallmans, G., Idahl, A., Krogh, V., et al. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0156-6 · Cited by 32
“Furthermore, prolactin levels increase in response to psychosocial and physical stress [9], which was associated with greater tumor burden and tumor invasiveness in a mouse model of ovarian cancer [10, 11].”
Dermatological Manifestations of Stress in Normal and Psychiatric Populations
Rodriguez-Vallecillo, E., & Woodbury-Fariña, M. A. (2014) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2014.08.009 · Cited by 36
Hasen, N. S., O’Leary, K. A., Auger, A. P., & Schuler, L. A. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0225 · Cited by 32
“Studies in rats have shown a relationship between social isolation and mammary tumors (9, 10), and social isolation of murine recipients of ovarian tumor xenografts increases tumor progression (11).”
BackgroundZhang, S., Wang, W., Liu, Z., & Wang, Z. (2019) · Cancer Medicine · doi:10.1002/cam4.1802 · Cited by 29
Optimization of Glioblastoma Mouse Orthotopic Xenograft Models for Translational Research.
Irtenkauf, S. M., Sobiechowski, S., Hasselbach, L. A., Nelson, K. K., Transou, A. D., Carlton, E. T., Mikkelsen, T., & deCarvalho, A. C. (2017) · PubMed Central · Cited by 28
Stress as a Possible Mechanism in Melanoma Progression
Sanzo, M. D., Colucci, R., Arunachalam, M., Berti, S., & Moretti, S. (2010) · Dermatology Research and Practice · doi:10.1155/2010/483493 · Cited by 29
“Tumors in stressed animals showed markedly increased vascularization and enhanced expression of VEGF, MMP-2, and MMP-9; it seems that angiogenic processes mediate the effects of stress on tumor growth in vivo [27].”
BackgroundPropranolol and breast cancer—a work in progress
Pantziarka, P., Bryan, B. A., Crispino, S., & Dickerson, E. B. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.ed82 · Cited by 35
Inside the Biology of the β3-Adrenoceptor
Pasha, A., Tondo, A., Favre, C., & Calvani, M. (2024) · Biomolecules · doi:10.3390/biom14020159 · Cited by 31
Trial watch: dexmedetomidine in cancer therapy
Provost, K. C. L., Kepp, O., Kroemer, G., & Bezu, L. (2024) · OncoImmunology · doi:10.1080/2162402x.2024.2327143 · Cited by 30
Chronic stress: a fourth etiology in tumorigenesis?
Khan, A., Song, M., & Dong, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02402-x · Cited by 33
“The activation of adrenergic receptors stimulates VEGF and matrix metalloproteinases (MMP) secretion to promote angiogenesis in human cancers [129–133].”
Sun, C., Shen, Y., Wang, F., Lu, T., & Zhang, J. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06657-2 · Cited by 31
“Thaker et al. [57] found that chronic stress promoted tumor growth and angiogenesis in a mouse model of ovarian cancer, increasing vessel density and causing abnormal vasculature, suggesting that activation of the SNS impairs vascular normalization, thereby limiting immune cell infiltration into…”
Tumour brain: Pretreatment cognitive and affective disorders caused by peripheral cancers
Mampay, M., Flint, M. S., & Sheridan, G. K. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15571 · Cited by 32
Thekdi, S. M., Milbury, K., Spelman, A. R., Wei, Q., Wood, C., Matin, S. F., Tannir, N. M., Jonasch, E. W., Pisters, L. L., & Cohen, L. G. (2015) · Psycho-Oncology · doi:10.1002/pon.3758 · Cited by 27
“PTSS may similarly influence cancer outcomes via direct effects on key physiological pathways, as suggested by work in animal cancer models demonstrating ‘stress’ promoting tumor progression and metastasis through adrenergic stimulation [34,35].”
BackgroundTumor dormancy and the neuroendocrine system: an undisclosed connection?
Zappalà, G., Green, P. A., & Cole, S. W. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9400-x · Cited by 28
Self-citationWoo, S., Yoon, M.-S., Kim, J., Hong, Y., Kim, M.-Y., Shin, S. S., & Yoon, M. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.015 · Cited by 29
Li, Y., Wan, H., Ma, R., Liu, T., Chen, Y., & Dong, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612822 · Cited by 28
“Even though stress is important for people’s rapid reaction to threats, chronic stress is associated with detrimental effects on physical health and adversely affects the immune, neuroendocrine, and central nervous systems, promoting the progression of diseases such as fat [4], cardiovascular disease [5], depression […”
BackgroundSelf-citationZhang, Z., Lv, Z. G., Lu, M., Li, H., & Zhou, J. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189121 · Cited by 36
Li, Y., Yu, H., Li, Z., Yin, K.-W., Jin, S., Chen, C.-C., Tan, M.-S., Zhang, C.-J., Liu, X.-H., Li, W.-P., et al. (2025) · Nature Cancer · doi:10.1038/s43018-025-01033-x · Cited by 36
“No statistical methods were used to pre-determine sample sizes but our sample sizes are similar to those reported in previous publications 5,6,67,68 .”
Self-citationβ-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells
Fjæstad, K. Y., Johansen, A. Z., Linder, H., Baker, K. J., Schattefor, M., Czajkowski, N. K., Thorseth, M., Siersbæk, M. S., Kurzay, A., Perez-Penco, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65048-9 · Cited by 28
Cancer neuroscience: signaling pathways and new therapeutic strategies for cancer
Zhang, S., Yuan, L., Lin, P., Yang, G., Zhou, X., Jinfu, X., Wu, M., & Huang, Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02364-y · Cited by 31
“120 On the other hand, tumors drive neurogenesis to initiate new nerve fi bers by the secretion of neurotrophic factors.”
Metadata
- Authors
- Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., Merritt, W. M., Lin, Y. G., Mangala, L. S., Kim, T. J., Coleman, R. L., Landen, C. N., Li, Y., Felix, E., Sanguino, A. M., Newman, R. A., Lloyd, M., Gershenson, D. M., Kundra, V., Lopez-Berestein, G., Lutgendorf, S. K., Cole, S. W., & Sood, A. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of California, Los Angeles (US)
- University of Iowa (US)
- Corresponding author
- Sood, Anil K
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 939-944
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2151356556
- Cited by
- 1,320
- References
- 31
- Citations by year
- 2026: 69 · 2025: 83 · 2024: 100 · 2023: 88 · 2022: 71 · 2021: 82 · 2020: 90 · 2019: 66 · 2018: 64 · 2017: 55 · 2016: 70 · 2015: 74 · 2014: 59 · 2013: 72 · 2012: 63
- FWCI
- 23.64
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-11-19)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Johnson and Johnson
- National Cancer Institute (CA10929801, U01CA213759, CA-104825, CA 11079301, R01CA104825, P50CA083639)
- National Institute of Allergy and Infectious Diseases (AI 52737, R01AI052737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Keywords
- chronic stress, ovarian carcinoma, tumor angiogenesis, tumor growth, beta2-adrenergic receptor, cAMP signaling, protein kinase A, catecholamines, vascular endothelial growth factor, matrix metalloproteinases, tumor invasion, orthotopic xenograft
- MeSH terms
- Animals, Carcinoma, Disease Models, Animal, Drug Combinations, Enzyme Inhibitors, Female, Humans, Isoproterenol, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Organ Size, Ovarian Neoplasms, Phthalazines, Pyridines, Radiography, Random Allocation, Stress, Psychological, Terbutaline, Transplantation, Heterologous, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Tumor Burden, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.